S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
Log in

Danakali Limited (DNK.AX) Stock Forecast, Price & News

Today's Range N/A
50-Day Range
MA: A$0.38
52-Week Range N/A
Volume155,644 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Danakali Limited engages in the exploration of minerals in Eritrea, East Africa. It focuses on the Colluli potash project located in the Danakil Depression region of Eritrea. The company was formerly known as South Boulder Mines Ltd. and changed its name to Danakali Limited in June 2015. Danakali Limited is based in Perth, Australia.


Overall MarketRank

0.38 out of 5 stars

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Industrial Metals & Minerals



Sales & Book Value

Annual Sales$-304,488.00
Book ValueA$0.20 per share



Next Earnings DateN/A
OptionableNot Optionable

Receive DNK News and Ratings via Email

Sign-up to receive the latest news and ratings for DNK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Danakali Limited (DNK.AX) (ASX:DNK) Frequently Asked Questions

What stocks does MarketBeat like better than Danakali Limited (DNK.AX)?

Wall Street analysts have given Danakali Limited (DNK.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Danakali Limited (DNK.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Danakali Limited (DNK.AX)'s earnings last quarter?

Danakali Limited (DNK.AX) (ASX:DNK) posted its earnings results on Wednesday, September, 12th. The company reported $0.00 earnings per share (EPS) for the quarter.
View Danakali Limited (DNK.AX)'s earnings history

Who are some of Danakali Limited (DNK.AX)'s key competitors?

What other stocks do shareholders of Danakali Limited (DNK.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danakali Limited (DNK.AX) investors own include Knowles (KN), Aurinia Pharmaceuticals (AUPH), Athenex (ATNX), Ascendis Pharma A/S (ASND), Ardelyx (ARDX), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO), AnPac Bio-Medical Science (ANPC), The Allstate (ALL) and Agility Health, Inc. (AHI.V) (AHI).

Who are Danakali Limited (DNK.AX)'s key executives?

Danakali Limited (DNK.AX)'s management team includes the following people:
  • Mr. Niels Wage, Chief Exec. Officer
  • Mr. Stuart Tarrant, Chief Financial Officer
  • Ms. Melissa Chapman, Joint-Company Sec.
  • Ms. Catherine Grant-Edwards C.A., Joint-Company Sec.
  • Dr. Roderick Joseph McEachern, Chief Operating Officer (Age 63)
  • Mark Riseley, Sr. Corp. Devel. Mang.

What is Danakali Limited (DNK.AX)'s stock symbol?

Danakali Limited (DNK.AX) trades on the ASX under the ticker symbol "DNK."

How big of a company is Danakali Limited (DNK.AX)?

Danakali Limited (DNK.AX) has a market capitalization of $0.00 and generates $-304,488.00 in revenue each year.

What is Danakali Limited (DNK.AX)'s official website?

The official website for Danakali Limited (DNK.AX) is www.danakali.com.au.

How can I contact Danakali Limited (DNK.AX)?

Danakali Limited (DNK.AX)'s mailing address is L 1 234 Churchill Ave, SUBIACO, WAS 6008, Australia. The company can be reached via phone at +61-8-63151444.

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.